Cargando…
Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
Severe cardiovascular complications can occur in coronavirus disease of 2019 (COVID-19) patients. Cardiac damage is attributed mostly to the aberrant host response to acute respiratory infection. However, direct infection of cardiac tissue by severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Autores principales: | Navaratnarajah, Chanakha K., Pease, David R., Halfmann, Peter J., Taye, Biruhalem, Barkhymer, Alison, Howell, Kyle G., Charlesworth, Jon E., Christensen, Trace A., Kawaoka, Yoshihiro, Cattaneo, Roberto, Schneider, Jay W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610601/ https://www.ncbi.nlm.nih.gov/pubmed/34613786 http://dx.doi.org/10.1128/JVI.01368-21 |
Ejemplares similares
-
B-AB18-03 SARS-COV-2 DIRECT CARDIAC DAMAGE THROUGH SPIKE-MEDIATED CARDIOMYOCYTE FUSION MAY CONTRIBUTE TO INCREASED ARRHYTHMIC RISK IN COVID-19
por: Clemens, Daniel J., et al.
Publicado: (2021) -
SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19
por: Clemens, Daniel J., et al.
Publicado: (2023) -
Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion
por: Kawase, Miyuki, et al.
Publicado: (2019) -
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
por: Hörnich, Bojan F., et al.
Publicado: (2021) -
N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Δ4-Desaturase 1-Independent Mechanism
por: Hayashi, Yasuhiro, et al.
Publicado: (2021)